ID
37753
Description
Study ID: 104864/517 Clinical Study ID: 104864/517 Study Title: A Phase I Study of Oral Topotecan as a Radiosensitizing Agent in Patients With Rectal Cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00158886 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Topotecan + Radiation therapy Trade Name: N/A Study Indication: Rectal Cancer, Carcinoma, Renal Cell
Keywords
Versions (1)
- 8/21/19 8/21/19 -
Copyright Holder
GlaxoSmithKline
Uploaded on
August 21, 2019
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Oral Topotecan as Radiosensitizing Agent in Patients with Rectal Cancer; NCT00158886
Topotecan Post-Study Minimal Follow-up Report
- StudyEvent: ODM
Description
Month of Report
Alias
- UMLS CUI-1
- C1704685
- UMLS CUI-2
- C0439231
Description
Follow-Up Report, Month
Data type
text
Alias
- UMLS CUI [1,1]
- C1704685
- UMLS CUI [1,2]
- C0439231
Description
Follow-Up Report, Month
Data type
text
Alias
- UMLS CUI [1,1]
- C1704685
- UMLS CUI [1,2]
- C0439231
Description
Outcome
Alias
- UMLS CUI-1
- C1547647
Description
Patient Outcome, Cessation of life
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C0011065
Description
Patient Outcome, Date last contact
Data type
date
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C0805839
Description
Patient Outcome, Lost to follow-up
Data type
boolean
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C1302313
Description
Patient Outcome, Disease Progression
Data type
text
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C0242656
Description
Patient Outcome, Disease Progression, Date in time
Data type
date
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C0242656
- UMLS CUI [1,3]
- C0011008
Description
Patient Outcome, Cancer treatment
Data type
text
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C0920425
Description
Patient Outcome, Cancer treatment, Start Date
Data type
date
Alias
- UMLS CUI [1,1]
- C1547647
- UMLS CUI [1,2]
- C0920425
- UMLS CUI [1,3]
- C0808070
Description
Form D
Alias
- UMLS CUI-1
- C0011065
Description
Cause of Death
Data type
text
Alias
- UMLS CUI [1]
- C0007465
Description
Cause of Death
Data type
text
Alias
- UMLS CUI [1]
- C0007465
Description
Date of death
Data type
date
Alias
- UMLS CUI [1]
- C1148348
Description
Cessation of life, Autopsy
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0011065
- UMLS CUI [1,2]
- C0004398
Description
Cessation of life, Autopsy, Finding
Data type
text
Alias
- UMLS CUI [1,1]
- C0011065
- UMLS CUI [1,2]
- C0004398
- UMLS CUI [1,3]
- C0243095
Description
Investigator's Signature
Alias
- UMLS CUI-1
- C2346576
Description
Investigator Signature
Data type
text
Alias
- UMLS CUI [1]
- C2346576
Description
Investigator Signature, Date in time
Data type
date
Alias
- UMLS CUI [1,1]
- C2346576
- UMLS CUI [1,2]
- C0011008
Similar models
Topotecan Post-Study Minimal Follow-up Report
- StudyEvent: ODM
C1300638 (UMLS CUI [1,2])
C0439231 (UMLS CUI [1,2])
C0439231 (UMLS CUI [1,2])
C0011065 (UMLS CUI [1,2])
C0805839 (UMLS CUI [1,2])
C1302313 (UMLS CUI [1,2])
C0242656 (UMLS CUI [1,2])
C0242656 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0920425 (UMLS CUI [1,2])
C0920425 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,3])
C0004398 (UMLS CUI [1,2])
C0004398 (UMLS CUI [1,2])
C0243095 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])